Wedbush Securities Inc Ampio Pharmaceuticals, Inc. Transaction History

Wedbush Securities Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$0.75 - $2.76 $49,500 - $182,160	-66,000 Closed	0 $0
Q3 2020 Oct 20, 2020	SELL	$0.61 - $1.17 $15,982 - $30,653	-26,200 Reduced 28.42%	66,000 $63,000
Q2 2020 Jul 16, 2020	SELL	$0.47 - $0.72 $18,095 - $27,720	-38,500 Reduced 29.46%	92,200 $59,000
Q1 2020 Apr 17, 2020	BUY	$0.36 - $0.74 $10,008 - $20,572	27,800 Added 27.02%	130,700 $54,000
Q3 2019 Oct 17, 2019	SELL	$0.38 - $0.52 $17,439 - $23,864	-45,893 Reduced 30.84%	102,900 $52,000
Q2 2019 Aug 01, 2019	SELL	$0.39 - $0.7 $69,420 - $124,599	-178,000 Reduced 54.47%	148,793 $58,000
Q1 2019 Apr 17, 2019	BUY	$0.43 - $0.68 $140,520 - $222,219	326,793 New	326,793 $184,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Market Cap $2.26M
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.